bw a868c has been researched along with ozagrel in 1 studies
| Studies (bw a868c) | Trials (bw a868c) | Recent Studies (post-2010) (bw a868c) | Studies (ozagrel) | Trials (ozagrel) | Recent Studies (post-2010) (ozagrel) |
|---|---|---|---|---|---|
| 47 | 0 | 11 | 529 | 31 | 37 |
| Protein | Taxonomy | bw a868c (IC50) | ozagrel (IC50) |
|---|---|---|---|
| cystic fibrosis transmembrane conductance regulator | Homo sapiens (human) | 3.43 | |
| Thromboxane-A synthase | Homo sapiens (human) | 0.0864 | |
| Thromboxane-A synthase | Rattus norvegicus (Norway rat) | 0.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gonzalez, AP; Menger, MD; Otto, G; Palma, P; Post, S; Rentsch, M | 1 |
1 other study(ies) available for bw a868c and ozagrel
| Article | Year |
|---|---|
Role of eicosanoids in reperfusion injury in rat liver transplantation.
Topics: Animals; Eicosanoids; Hydantoins; Indoles; Leukotriene Antagonists; Liver Transplantation; Male; Methacrylates; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Lew; Receptors, Thromboxane; Reperfusion Injury; Thromboxane A2; Thromboxane-A Synthase | 1993 |